Metropolis Healthcare Ltd.
NSE: METROPOLIS | BSE: 542650
₹566.25
₹-6.40
(-1.12%)
As on 11-Aug-2026IST
Market cap
₹11,872 Cr
Revenue (TTM)
₹1,710 Cr
P/E Ratio
58.9
P/B Ratio
7.6
Div. Yield
0.9 %
Quality Score
9/10
Growth Score
4/10
Valuation Score
4/10
Momentum Score
3/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹202 Cr
-
ROE
13.5 %
-
ROCE
20 %
-
Industry P/E
60.53
-
EV/EBITDA
26.6
-
Debt to Equity
0
-
Book Value
₹75.2
-
EPS
₹24.6
-
Face value
2
-
Shares outstanding
207,387,568
10 Years Aggregate
CFO
₹2,137.74 Cr
EBITDA
₹2,700.18 Cr
Net Profit
₹1,476.84 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Metropolis Health
| 17.4 | -0.3 | 3.0 | 12.8 | 17.1 | -4.0 | -- |
|
BSE Healthcare
| 18.3 | 2.8 | 10.4 | 19.0 | 22.0 | 14.3 | 12.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Metropolis Health
| -6.2 | 24.0 | 26.4 | -61.4 | 70.8 | 36.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Metropolis Health
|
566.3 | 11,871.9 | 1,710.0 | 202.8 | 16.8 | 14.1 | 58.9 | 7.6 |
| 1,949.9 | 32,802.7 | 2,890.8 | 546.3 | 23.0 | 23 | 60.5 | 12.6 | |
| 1,440.4 | 39,680.1 | 4,683.4 | 552.3 | 15.6 | 14.9 | 71.3 | 9.6 | |
| 813.1 | 34,413.2 | 4,212.5 | 190.8 | 11.9 | 9.4 | 168.4 | 9.1 | |
| 301.1 | 965.8 | 1,467.7 | -26.1 | -5.0 | -2.9 | -- | 1.5 | |
| 649.4 | 9,893.7 | 876.0 | 174.0 | 25.3 | 32.4 | 56.1 | 15.7 | |
| 1,428.2 | 14,345.0 | 857.1 | 187.5 | 31.0 | 20.6 | 76.5 | 14.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Sticking with experts during uncertainty
4 min read•By Rajan Gulati
About Metropolis Health
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests;... advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. In addition, the company develops and deals in technology driven products and services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India. Read more
-
Incorporated
2000
-
Chairman
Ameera Shah
-
Managing Director
Surendran Chemmenkotil
-
Group
Metropolis
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Metropolis Healthcare Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Metropolis Health
What is the current share price of Metropolis Healthcare Ltd Today?
The share price of Metropolis Healthcare Ltd is ₹566.25 (NSE) and ₹565.45 (BSE) as of 11-Aug-2026 IST. Metropolis Healthcare Ltd has given a return of 17.14% in the last 3 years.
What is the current PB & PE ratio of Metropolis Healthcare Ltd?
The P/E ratio of Metropolis Healthcare Ltd is 58.88 times as on 10-Aug-2026, a 3 discount to its peers’ median range of 60.53 times.
The P/B ratio of Metropolis Healthcare Ltd is 7.61 times as on 10-Aug-2026, a 21 discount to its peers’ median range of 9.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
47.33
|
5.99
|
|
2025
|
13.96
|
6.12
|
|
2024
|
69.19
|
8.13
|
|
2023
|
44.76
|
6.52
|
|
2022
|
48.66
|
11.92
|
What is the 52 Week High and Low of Metropolis Healthcare Ltd?
The 52-week high and low of Metropolis Healthcare Ltd are Rs 609.05 and Rs 412.25 as of 11-Aug-2026.
What is the market cap of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd has a market capitalisation of ₹ 11,872 Cr as on 10-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Metropolis Healthcare Ltd?
Before investing in Metropolis Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.